Insilico Medicine Partners with UAEU to Drive Biotech Innovation in the Middle East
CompanyDeals

Insilico Medicine Partners with UAEU to Drive Biotech Innovation in the Middle East

Bio-Thera Partners with SteinCares for Biosimilar Commercialization in Latin America
CompanyDeals

Bio-Thera Partners with SteinCares for Biosimilar Commercialization in Latin America

Vcanbio Submits Clinical Trial Application for VUM02 in Severe Pneumonia Treatment
CompanyDrug

Vcanbio Submits Clinical Trial Application for VUM02 in Severe Pneumonia Treatment

Simcere Halts R&D on Alzheimer's Drug Candidates Amid Pipeline Setbacks
CompanyDrug

Simcere Halts R&D on Alzheimer’s Drug Candidates Amid Pipeline Setbacks

Yifan Pharma Wins NMPA Approval for Norditropin Biosimilar Trial
CompanyDrug

Yifan Pharma Wins NMPA Approval for Norditropin Biosimilar Trial

GSK's Linerixibat Accepted for EMA Review for Cholestatic Pruritus in PBC
CompanyDrug

GSK’s Linerixibat Accepted for EMA Review for Cholestatic Pruritus in PBC

Sanofi's Sarclisa Recommended for EU Approval in Newly Diagnosed Multiple Myeloma
CompanyDrug

Sanofi’s Sarclisa Recommended for EU Approval in Newly Diagnosed Multiple Myeloma

Beijing Tightens Price Risk Management for Scarce Medications
Policy / Regulatory

Beijing Tightens Price Risk Management for Scarce Medications

Cloudbreak Pharma's IPO Raises HKD 522M for Ophthalmic Drug Development
CompanyDeals

Cloudbreak Pharma’s IPO Raises HKD 522M for Ophthalmic Drug Development

Formation Bio Licenses Gusacitinib to Sanofi for Novel Indication Study
CompanyDeals

Formation Bio Licenses Gusacitinib to Sanofi for Novel Indication Study

Novo Nordisk's Ozempic Gets Positive CHMP Opinion for Peripheral Artery Disease
CompanyDrug

Novo Nordisk’s Ozempic Gets Positive CHMP Opinion for Peripheral Artery Disease

Illumina to Acquire SomaLogic for $350M to Expand Proteomics Tech Integration
CompanyDeals

Illumina to Acquire SomaLogic for $350M to Expand Proteomics Tech Integration